The 3D-ASCr scale: A revalidation of the core dimensions of the Altered States of Consciousness Rating Scale 5D(11)-ASC for psychedelic research
Year: 2025
Type: article
Language: en
Topic: Psychedelics and Drug Studies
Authors and affiliations:
raw_author_name: Kurt Stocker
raw_affiliation_strings: Chair of Cognitive Science, Department of Humanities, Social and Political Sciences, ETH Swiss Federal Institute of Technology Zurich, Switzerland
Department of Psychology, University of Zurich, Switzerland
Faculty of Psychology, UniDistance Suisse, Brig, Switzerland
Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Matthias Hartmann
raw_affiliation_strings: Faculty of Psychology, UniDistance Suisse, Brig, Switzerland
raw_author_name: Yasmin Schmid
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Severin B. Vogt
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Anna M. Becker
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Laura Ley
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Isabelle Straumann
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Denis Arikci
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Aaron Klaiber
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Livio Erne
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Patrick Vizeli
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Friederike Holze
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland
raw_author_name: Matthias E. Liechti
raw_affiliation_strings: Psychopharmacology Research, Division of Clinical Pharmacology &amp; Toxicology, Department of Clinical Research, University Hospital Basel, University of Basel, Switzerland